The choice of an International Searching Authority is one of the few irreversible strategic decisions in the PCT lifecycle. While formally procedural, ISA selection materially influences examiner perception, prosecution speed, cost concentration, Patent Prosecution Highway eligibility, and the global signalling effect of the International Search Report.
For Indian applicants, the practical choice most often lies between ISA/India (IN), ISA/United States (US), and ISA/Europe (EP). Each represents a fundamentally different prosecution philosophy. There is no universally best ISA choice. There is only a contextually correct one.
The Role of the International Searching Authority in PCT Strategy
Defining the ISA: Jurisdiction and competency rules for Indian applicants
Under the PCT framework, the International Searching Authority is appointed based on the Receiving Office through which the PCT application is filed.
For applications filed via RO/IN (Indian Patent Office) or RO/IB, Indian applicants may select from multiple competent ISAs. As of 2025–2026, this typically includes ISA/IN, ISA/US, ISA/EP, ISA/AU, ISA/JP, and ISA/CN, subject to current WIPO competency notifications.
The ISA must be selected at the time of filing Form PCT/RO/101. Once the search fee is paid and the search process begins, the choice is effectively locked. Changing the ISA would normally require withdrawal and refiling, with loss of the original international filing date.
Legal impact of the International Search Report on national phase entry
The International Search Report identifies prior art relevant to novelty and inventive step. Although legally non-binding, based on current IPO, USPTO, EPO, and CNIPA examination practice, the ISR carries substantial persuasive value.
Many national offices, particularly those with constrained search capacity, treat a reputable ISR as a starting point and may conduct only confirmatory searching. A strong ISR often compresses prosecution timelines. A negative ISR can shape examiner posture across multiple jurisdictions.
Procedural significance of the Written Opinion in global prosecution
The Written Opinion of the ISA is the first formal articulation of patentability risk. It directly informs decisions on:
· Article 19 amendments to claims
· Whether to enter Chapter II
· Whether to abandon or narrow the filing strategy before national phase costs accrue
Once published at 18 months, the Written Opinion becomes a global reference document that national examiners can cite.
ISA/India (IN): Economic Strategy and Local Expedited Examination
Statutory fee structures for startups and small entities (2025–2026)
ISA/IN is structurally the lowest-cost ISA available to Indian applicants.
Indicative international search fees are:
· Startups and small entities: approximately INR 10,000
· Large entities: approximately INR 40,000
In contrast, ISA/US and ISA/EP fees are denominated in USD and EUR respectively and can be an order of magnitude higher. For capital-constrained applicants, ISA/IN materially lowers early-stage burn without eliminating downstream options.
The statutory link to Rule 24C and expedited Indian national phase
A unique strategic advantage of ISA/IN is its statutory linkage to Rule 24C of the Indian Patent Rules.
If India is selected as the ISA or IPEA, the applicant becomes eligible to request expedited examination in the Indian national phase. Based on current IPO practice, this can reduce time to grant to 6–12 months.
For India-first commercialization, manufacturing, or government procurement strategies, this linkage alone can justify ISA/IN selection.
Technical strengths in traditional knowledge and cost-effective IT searches
The Indian Patent Office has direct access to the Traditional Knowledge Digital Library (TKDL). This makes ISA/IN particularly effective for inventions intersecting with herbal formulations, agriculture, or traditional chemistry.
In software and electronics, ISA/IN searches are improving in consistency, while maintaining a comparatively neutral tone that avoids early global prejudice.
ISA/United States (USPTO): Speed and Tech-Sector Specialization
Strategic benefits for portfolios targeting the North American market
Where the United States is the primary enforcement jurisdiction, ISA/US offers examiner continuity advantages.
When the same or a closely related art unit handles both the ISR and the US national phase, prosecution becomes more predictable. Claim scope discussions often begin earlier and with fewer procedural resets.
Search reliability for software, biotechnology, and medical devices
USPTO examiners operate within highly specialized technical art units. For software platforms, AI architectures, biotech sequences, and regulated medical devices, ISA/US searches are generally well-aligned with US national phase realities.
Written Opinions may flag subject matter issues, but usually in language tailored to US jurisprudence rather than categorical exclusions.
Fee reductions and limitations for micro-entities and small entities
ISA/US offers a tiered fee regime:
· Large entity: full fee
· Small entity: approximately 60 percent reduction
· Micro-entity: approximately 80 percent reduction
For Indian startups that qualify as US micro-entities, ISA/US can become cost-competitive relative to its strategic value, though it remains more expensive than ISA/IN.
ISA/Europe (EPO): The Rigor Strategy for High-Value Assets
Eliminating supplementary search fees in the European regional phase
If the EPO acts as ISA, the applicant avoids paying the supplementary European search fee at regional phase entry. This partially offsets the higher upfront ISA/EP fee where Europe is a guaranteed filing destination.
PCT Direct and pre-emptive engagement with earlier search results
Under the EPO’s PCT Direct program, applicants may submit informal comments addressing objections raised in an earlier EPO search. The ISA examiner is required to consider these comments when preparing the ISR and Written Opinion.
This mechanism allows early issue resolution but assumes high drafting discipline and confidence in inventive step.
The EPO search standard and enforcement readiness
ISA/EP conducts the most exhaustive searches, including extensive non-patent literature. This rigor reduces post-grant vulnerability but materially increases the risk of early negative opinions.
A clean or manageable EPO ISR carries exceptional weight globally. A negative one can create systemic resistance across national phases.
Comparative Decision Matrix: Cost, Quality, and Subject Matter Depth
Database access comparison and prior art depth
|
ISA |
Key strengths |
Typical limitations |
|
ISA/EP |
Deep NPL, structured inventive step analysis |
High cost, rigid reasoning |
|
ISA/US |
Software, biotech, medical devices |
Less global NPL |
|
ISA/IN |
TKDL, cost efficiency, flexibility |
Variable depth in some fields |
Divergent approaches to subject matter eligibility
Examiner training inevitably influences Written Opinions. ISA/IN examiners often reflect Indian statutory exclusions. ISA/EP examiners apply the technical character framework of Article 52 EPC. ISA/US examiners frame eligibility through US judicial doctrine.
Strategic applicants align ISA choice with the drafting philosophy best suited to their invention.
Influence of ISA selection on PPH eligibility
Positive ISRs from ISA/EP and ISA/US are accepted by a wider range of PPH partner offices. ISA/IN acceptance is expanding but remains more limited. Current bilateral arrangements should always be verified at filing.
Strategic Checklist for ISA Selection
Primary market and enforcement focus
Budget tolerance and timing sensitivity
India-specific acceleration needs
Risk appetite for early global prejudice
Technology maturity and prior art confidence
Frequently Asked Questions (FAQs)
Is
there a single best ISA choice
No. ISA
selection is context-dependent and should be aligned with enforcement geography
and risk tolerance.
Can
the ISA be changed after filing
Generally no.
The choice is locked once the search begins.
Does a
negative ISR guarantee rejection
No, but it
materially increases prosecution friction.
Is
ISA/IN legally weaker
No. It is
procedurally equivalent but strategically different.
Does
ISA choice affect national phase eligibility
No. It affects
perception, not legal entitlement.
Can
ISA choice influence grant speed
Indirectly,
through expedited examination and examiner reliance.
Is
ISA/EP always safer
Only if the
invention can withstand rigorous inventive step scrutiny.
Does
ISA choice affect Chapter II
Yes. IPEA
competency usually tracks ISA selection.